Boston Scientific Corporation (BSX) — Financial statements
Income statement, balance sheet, and cash flow for Boston Scientific Corporation — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 20,074↑19.9% | 16,747↑17.6% | 14,240↑12.3% | 12,682↑6.7% | 11,888 | |
| Cost of Revenue | 6,221↓4.0% | 6,480↑19.8% | 5,409↑8.9% | 4,968↑12.2% | 4,427 | |
| Gross Profit | 13,853↑34.9% | 10,267↑16.3% | 8,831↑14.5% | 7,714↑3.4% | 7,461 | |
| Operating Expenses | ||||||
| R&D Expenses | 2,052↑27.1% | 1,615↑14.2% | 1,414↑6.9% | 1,323↑9.9% | 1,204 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 6,887↑15.1% | 5,984↑15.3% | 5,190↑14.8% | 4,520↑5.5% | 4,286 | |
| Other Expenses | 943↑2757.6% | 33↓28.3% | 46↓2.1% | 47↓4.1% | 49 | |
| Operating Expenses | 9,882↑29.5% | 7,632↑14.8% | 6,650↑12.9% | 5,890↑6.3% | 5,539 | |
| Total Costs & Expenses | 16,103↑14.1% | 14,112↑17.0% | 12,059↑11.1% | 10,858↑9.0% | 9,966 | |
| Operating Results | ||||||
| Operating Income | 3,971↑50.7% | 2,635↑20.8% | 2,181↑19.6% | 1,824↓5.1% | 1,922 | |
| Depreciation & Amortization | 0.00↓100.0% | 1,269↑6.1% | 1,196↑5.3% | 1,136↑3.9% | 1,093 | |
| EBITDA | 3,733↓5.2% | 3,938↑14.0% | 3,453↑26.0% | 2,741↑8.9% | 2,518 | |
| EBIT | 3,733↑39.9% | 2,669↑18.3% | 2,257↑40.6% | 1,605↑12.6% | 1,425 | |
| Interest & Other Income | ||||||
| Net Interest Income | -349↓24.6% | -280↓12.0% | -250↑44.9% | -454↓31.6% | -345 | |
| Interest Income | 0.00↓100.0% | 107↑386.4% | 22↑120.0% | 10↑150.0% | 4 | |
| Interest Expense | 349↓9.8% | 387↑42.3% | 272↓41.4% | 464↑33.0% | 349 | |
| Non-Operating Income | 238↑800.0% | -34↑55.3% | -76↓134.7% | 219↓55.9% | 497 | |
| Other Income / Expenses | -586↓66.0% | -353↓80.1% | -196↑71.3% | -683↑19.3% | -846 | |
| Income Before Tax | 3,385↑48.3% | 2,282↑15.0% | 1,985↑74.0% | 1,141↑6.0% | 1,076 | |
| Income Tax Expense | 493↑13.1% | 436↑10.9% | 393↓11.3% | 443↑1130.6% | 36 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 2,892↑56.7% | 1,846↑16.0% | 1,592↑128.1% | 698↓32.9% | 1,040 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 2,886↑55.7% | 1,854↑16.4% | 1,593↑128.2% | 698↓32.9% | 1,040 | |
| Bottom-Line Net Income | 2,886↑55.7% | 1,853↑18.0% | 1,570↑144.5% | 642↓34.8% | 985 | |
| EPS (Basic) | 1.96↑55.6% | 1.26↑16.6% | 1.08↑140.8% | 0.45↓35.2% | 0.69 | |
| EPS (Diluted) | 1.94↑55.2% | 1.25↑16.5% | 1.07↑140.6% | 0.45↓35.1% | 0.69 | |
| Weighted Average Shares | 1,480↑0.6% | 1,472↑1.3% | 1,453↑1.6% | 1,431↑0.6% | 1,422 | |
| Weighted Average Diluted Shares | 1,495↑0.6% | 1,486↑1.5% | 1,464↑1.7% | 1,440↑0.4% | 1,434 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.